Drug Profile


Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Unknown
  • Developer LC Chemical Corporation; Merck & Co; Nonindustrial source; Unknown
  • Class Anti-ischaemics; Antiarrhythmics; Cardiotonics; Lactones; Sesquiterpenes; Small molecules
  • Mechanism of Action Calcium channel antagonists; Calcium-transporting ATPase inhibitors; JNK mitogen-activated protein kinase modulators; P-glycoprotein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Arrhythmias; Cancer; Heart failure; Ischaemic heart disorders

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in Singapore
  • 19 Nov 2009 Preclinical trials in Cancer in Singapore (unspecified route)
  • 19 Nov 2009 Pharmacodynamics data from a preclinical trial in Cancer presented at the 21st AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (AACR-NCI-EORTC-2009)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top